Skip to main content
. 2024 May 21;11:1387853. doi: 10.3389/fvets.2024.1387853

Table 2.

Results of differential metabolite multiple analysis.

ID Name Formula m/z Retention time (min) log2FC Regulated
neg_6622 Tricosanoylglycine C25H49NO3 456.37 7.88 37.11 Up
pos_7083 1-Tricosanol C23H48O 379.33 3.28 36.80 Up
neg_1289 Sambacolignoside C43H54O22 921.29 0.70 36.29 Up
pos_1086 Kanzonol T C25H26O7 915.31 0.70 35.38 Up
pos_12100 Nemonoxacin C20H25N3O4 354.18 4.14 35.34 Up
pos_11933 2-Benzylidene-1-heptanol C14H20O 222.19 4.08 35.22 Up
pos_11705 Lotaustralin C11H19NO6 279.15 4.02 35.19 Up
pos_13943 FMNH2 C17H23N4O9P 481.11 5.43 35.07 Up
neg_1292 Probenecid Glucuronide C19H27NO10S 981.29 0.70 35.06 Up
pos_14727 (Z)-7-Hexadecen-1,16-olide C16H28O2 527.41 6.94 35.01 Up
neg_1212 (13Z,16Z)-Docosadienoyl-CoA C43H74N7O17P3S 1120.39 0.70 34.86 Up
pos_14363 Herculin C16H29NO 234.22 6.30 34.58 Up
pos_13944 Coriandrin C13H10O4 483.11 5.43 34.37 Up
pos_14513 N2-Galacturonyl-L-lysine C12H22N2O8 340.17 6.67 34.19 Up
pos_17309 Pyridinoline C18H28N4O8 451.18 9.52 34.13 Up
pos_13603 3-Heptylpyridine C12H19N 195.19 5.06 34.10 Up
pos_13914 4-Amino-3-hydroxybutanoylcarnitine C11H22N2O5 280.18 5.37 34.03 Up
pos_13931 Pantoyllactone glucoside C12H20O8 331.08 5.41 33.75 Up
pos_11369 2-Amino-5-formylamino-6-(5-phospho-D-ribosylamino)pyrimidin-4(3H)-one C10H16N5O9P 399.11 3.93 33.68 Up
neg_1285 (1-(2-(Methylsulfonamido)ethyl)piperidin-4-yl)methyl 5-fluoro-2-methoxy-1H-indole-3-carboxylate C19H26FN3O5S 899.31 0.70 33.60 Up
neg_4335 Linalool oxide D 3-(apiosyl-(1->6)-glucoside) C21H36O11 463.22 3.27 −29.65 Down
neg_1374 Ile-Val-Val C16H31N3O4 364.20 0.75 −29.76 Down
neg_3616 Rotundifoline C22H28N2O5 421.17 2.63 −29.96 Down
neg_1905 Labetalol C19H24N2O3 349.15 1.91 −30.15 Down
neg_4644 Bursin C14H25N7O3 374.17 3.52 −30.19 Down
neg_1726 2-Isopropyl-5-methoxypyrazine C8H12N2O 349.19 1.14 −30.21 Down
neg_5099 Periplocin C36H56O13 741.37 3.97 −30.51 Down
neg_1744 Histidyltryptophan C17H19N5O3 340.14 1.20 −30.55 Down
neg_4478 LysoPE (20:4(5Z,8Z,11Z,14Z)/0:0) C25H44NO7P 536.25 3.38 −30.62 Down
neg_5581 CDP-DG [a-21:0/20:4(5Z,8Z,11Z,14Z)-OH (20)] C53H91N3O16P2 1108.56 4.85 −30.65 Down
neg_1177 2′-C-Methylcytidine C10H15N3O5 513.21 0.68 −31.05 Down
neg_4257 N-Docosahexaenoyl Aspartic acid C26H37NO5 442.27 3.20 −31.07 Down
neg_4772 Asp Phe Val Glu C23H32N4O9 507.21 3.63 −31.25 Down
neg_21 Solithromycin C43H65FN6O10 889.46 0.47 −31.37 Down
neg_5587 Dioncophylline A C24H27NO3 799.40 4.89 −31.38 Down
neg_3144 Muzanzagenin C27H38O5 477.25 2.06 −31.50 Down
neg_3128 Hypochoeroside A C21H32O9 449.18 2.02 −32.02 Down
neg_3713 Undecylprodigiosin C25H35N3O 428.25 2.73 −32.17 Down
neg_3530 Cinobufotalin C26H34O7 493.21 2.52 −32.48 Down
neg_1823 2-(Ethylamino)-4,5-dihydroxybenzamide C9H12N2O3 437.17 1.64 −32.48 Down